Portage Biotech (NASDAQ:ALP) and Mogo (NASDAQ:MOGO) Critical Analysis

Mogo (NASDAQ:MOGO) and Portage Biotech (NASDAQ:ALP) are both small-cap technology companies, but which is the superior investment? We will contrast the two businesses based on the strength of their institutional ownership, dividends, profitability, risk, valuation, earnings and analyst recommendations.

Valuation and Earnings

This table compares Mogo and Portage Biotech”s top-line revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Mogo	$69.27 million	0.38	-$9.98 million	$0.23	4.74
Portage Biotech	$100,000.00	39.71	-$38.63 million	($8.18)	-0.02

Mogo has higher revenue and earnings than Portage Biotech. Portage Biotech is trading at a lower price-to-earnings ratio than Mogo, indicating that it is currently the more affordable of the two stocks.

Insider and Institutional Ownership

14.8% of Mogo shares are owned by institutional investors. Comparatively, 13.4% of Portage Biotech shares are owned by institutional investors. 12.3% of Mogo shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.

Risk and Volatility

Mogo has a beta of 2.71, meaning that its stock price is 171% more volatile than the S&P 500. Comparatively, Portage Biotech has a beta of 0.61, meaning that its stock price is 39% less volatile than the S&P 500.

Profitability

This table compares Mogo and Portage Biotech’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Mogo	11.41%	7.78%	3.34%
Portage Biotech	N/A	N/A	N/A

Analyst Recommendations

This is a summary of recent ratings for Mogo and Portage Biotech, as reported by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Mogo	1	1	1	0	2.00
Portage Biotech	1	2	0	0	1.67

Mogo currently has a consensus price target of $4.00, indicating a potential upside of 266.97%. Portage Biotech has a consensus price target of $0.25, indicating a potential upside of 47.75%. Given Mogo’s stronger consensus rating and higher possible upside, analysts clearly believe Mogo is more favorable than Portage Biotech.

Summary

Mogo beats Portage Biotech on 13 of the 14 factors compared between the two stocks.

About Mogo

Mogo Inc. operates as a digital finance company in Canada, Europe, and internationally. The company's digital solutions help build wealth and achieve financial freedom. It provides MogoTrade, a stock trading app; Moka; and MogoMoney that provides online personal loans. The company also offers digital loans and mortgages; and operates a digital payments platform that powers next-generation card programs for both global corporations and fintech companies in Europe and Canada. Mogo Inc. is headquartered in Vancouver, Canada.

About Portage Biotech

Portage Biotech Inc., together with its subsidiaries, researches and develops pharmaceutical and biotechnology products. The company’s product includes IMM60, an iNKT cell activator; IMM65, a PLGA-nanoparticle combined with a NY-ESO-1 peptide vaccine; INT230-6 that is in Phase I/II clinical trials for the treatment of solid tumors; STING, a small molecule that binds to the stimulator of interferon genes in cancer; CellPorter, a cell permeable peptide platform technology derived from human proteins; PPL-003, an ophthalmic solution; and SBI-101, a blood-conditioning technology to restore balance to the immune system after acute vital organ injury, such as acute kidney injury. It also focuses on nanolipogel technology for use in immune-oncology; and antibodies against a novel T-cell for use as a monotherapy and combination therapy for solid and haematological malignancies. In addition, the company develops antibodies implicated in the inflammatory tumor and tumor-infiltrating immune cell microenvironments; and FOXO4-P53 modulator and C-RAF inhibitor. Portage Biotech Inc. is based in Tortola, British Virgin Islands.